TY - JOUR
T1 - ESHRE guideline
T2 - Management of women with endometriosis
AU - Dunselman, G. A.J.
AU - Vermeulen, N.
AU - Becker, C.
AU - Calhaz-Jorge, C.
AU - D'Hooghe, T.
AU - De Bie, B.
AU - Heikinheimo, O.
AU - Horne, A. W.
AU - Kiesel, L.
AU - Nap, A.
AU - Prentice, A.
AU - Saridogan, E.
AU - Soriano, D.
AU - Nelen, W.
N1 - Funding Information:
G.A.J.D. reports personal fees from Abbott, outside the submitted work. N.V. has nothing to disclose. C.B. reports grants from Bayer and personal fees from Roche Diagnostics, outside the submitted work. C.C.-J. reports personal fees from MSD, personal fees from Gedeon-Richter, outside the submitted work. T.D. reports grants and personal fees from Merck Serono, grants and personal fees from Schering Plough, grants and personal fees from Ferring, grants and personal fees from Bayer Healthcare, personal fees from Astellas, personal fees from Preglem, personal fees from Roche, personal fees from Proteomika, outside the submitted work. O.H. reports personal fees from Bayer, personal fees from Gideon-Richter and personal fees from MSD, outside the submitted work. A.W.H. has nothing to disclose. L.K. reports personal fees from Bayer, outside the submitted work. A.N. reports personal fees from MSD, personal fees from Merck-Serono, outside the submitted work. A.P. has nothing to disclose. E.S. reports personal fees from Ethicon, personal fees from Gedeon-Richter, personal fees from Bayer-Schering, outside the submitted work. D.S. reports personal fees from Bayer, outside the submitted work. W.N. reports a personal fee from RCOG, outside the submitted work.
PY - 2014/3
Y1 - 2014/3
N2 - STUDY QUESTIONWhat is the optimal management of women with endometriosis based on the best available evidence in the literature?SUMMARY ANSWERUsing the structured methodology of the Manual for ESHRE Guideline Development, 83 recommendations were formulated that answered the 22 key questions on optimal management of women with endometriosis.WHAT IS KNOWN ALREADYThe European Society of Human Reproduction and Embryology (ESHRE) guideline for the diagnosis and treatment of endometriosis (2005) has been a reference point for best clinical care in endometriosis for years, but this guideline was in need of updating.STUDY DESIGN, SIZE, DURATIONThis guideline was produced by a group of experts in the field using the methodology of the Manual for ESHRE Guideline Development, including a thorough systematic search of the literature, quality assessment of the included papers up to January 2012 and consensus within the guideline group on all recommendations. To ensure input from women with endometriosis, a patient representative was part of the guideline development group. In addition, patient and additional clinical input was collected during the scoping and review phase of the guideline.PARTICIPANTS/MATERIALS, SETTING, METHODSNA.MAIN RESULTS AND THE ROLE OF CHANCEThe guideline provides 83 recommendations on diagnosis of endometriosis and on the treatment of endometriosis-associated pain and infertility, on the management of women in whom the disease is found incidentally (without pain or infertility), on prevention of recurrence of disease and/or painful symptoms, on treatment of menopausal symptoms in patients with a history of endometriosis and on the possible association of endometriosis and malignancy.LIMITATIONS, REASONS FOR CAUTIONWe identified several areas in care of women with endometriosis for which robust evidence is lacking. These areas were addressed by formulating good practice points (GPP), based on the expert opinion of the guideline group members.WIDER IMPLICATIONS OF THE FINDINGSSince 32 out of the 83 recommendations for the management of women with endometriosis could not be based on high level evidence and therefore were GPP, the guideline group formulated research recommendations to guide future research with the aim of increasing the body of evidence.
AB - STUDY QUESTIONWhat is the optimal management of women with endometriosis based on the best available evidence in the literature?SUMMARY ANSWERUsing the structured methodology of the Manual for ESHRE Guideline Development, 83 recommendations were formulated that answered the 22 key questions on optimal management of women with endometriosis.WHAT IS KNOWN ALREADYThe European Society of Human Reproduction and Embryology (ESHRE) guideline for the diagnosis and treatment of endometriosis (2005) has been a reference point for best clinical care in endometriosis for years, but this guideline was in need of updating.STUDY DESIGN, SIZE, DURATIONThis guideline was produced by a group of experts in the field using the methodology of the Manual for ESHRE Guideline Development, including a thorough systematic search of the literature, quality assessment of the included papers up to January 2012 and consensus within the guideline group on all recommendations. To ensure input from women with endometriosis, a patient representative was part of the guideline development group. In addition, patient and additional clinical input was collected during the scoping and review phase of the guideline.PARTICIPANTS/MATERIALS, SETTING, METHODSNA.MAIN RESULTS AND THE ROLE OF CHANCEThe guideline provides 83 recommendations on diagnosis of endometriosis and on the treatment of endometriosis-associated pain and infertility, on the management of women in whom the disease is found incidentally (without pain or infertility), on prevention of recurrence of disease and/or painful symptoms, on treatment of menopausal symptoms in patients with a history of endometriosis and on the possible association of endometriosis and malignancy.LIMITATIONS, REASONS FOR CAUTIONWe identified several areas in care of women with endometriosis for which robust evidence is lacking. These areas were addressed by formulating good practice points (GPP), based on the expert opinion of the guideline group members.WIDER IMPLICATIONS OF THE FINDINGSSince 32 out of the 83 recommendations for the management of women with endometriosis could not be based on high level evidence and therefore were GPP, the guideline group formulated research recommendations to guide future research with the aim of increasing the body of evidence.
KW - European Society of Human Reproduction and Embryology
KW - endometriosis
KW - evidence based
KW - guideline
UR - http://www.scopus.com/inward/record.url?scp=84894229513&partnerID=8YFLogxK
U2 - 10.1093/humrep/det457
DO - 10.1093/humrep/det457
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 24435778
AN - SCOPUS:84894229513
SN - 0268-1161
VL - 29
SP - 400
EP - 412
JO - Human Reproduction
JF - Human Reproduction
IS - 3
ER -